These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 7332041)

  • 41. Recognizing and treating depressed patients with maprotiline.
    Lerfald SC
    Md State Med J; 1982 Nov; 31(11):44-7. PubMed ID: 7176695
    [No Abstract]   [Full Text] [Related]  

  • 42. [Ambulatory treatment of larvate depressions with maprotiline ].
    Vencovský E
    Cesk Psychiatr; 1982 Jun; 78(3):185-9. PubMed ID: 7116496
    [No Abstract]   [Full Text] [Related]  

  • 43. [Our experiences in the treatment of pharmacoresistent depressions with maprotiline].
    Rektor L; Misaurec J; Horká E; Cerná V
    Act Nerv Super (Praha); 1982 May; 24(2):101-5. PubMed ID: 7102221
    [No Abstract]   [Full Text] [Related]  

  • 44. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of antidepressants in childhood: results of maprotiline (Ludiomil) treatment in 20 cases.
    Minuti E; Gallo V
    Adv Biochem Psychopharmacol; 1982; 32():223-7. PubMed ID: 7090893
    [No Abstract]   [Full Text] [Related]  

  • 46. Mianserin versus maprotiline in patients with a depressive syndrome.
    Indaco A; Orefice G; Carrieri P
    Acta Neurol (Napoli); 1984 Apr; 6(2):140-6. PubMed ID: 6741655
    [No Abstract]   [Full Text] [Related]  

  • 47. [The antidepressant viloxazin. A multicenter study under practice conditions].
    Rüther E
    Fortschr Med; 1982 May; 100(18):864-70. PubMed ID: 6124490
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An overview of side effects and long-term experience with nomifensine from United States clinical trials.
    Yakabow AL; Hardiman S; Nash RJ
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):96-101. PubMed ID: 6370985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Drug therapy profile of viloxazine. Open clinical trial with 34 patients].
    Pérez de Francisco C
    Neurol Neurocir Psiquiatr; 1976; 17(2):115-21. PubMed ID: 1052716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EEG characteristics of clinically defined on-drug-responders and non-responders--a comparison clomipramine vs. maprotiline.
    Ulrich G; Haug HJ; Stieglitz RD; Fähndrich E
    Pharmacopsychiatry; 1988 Nov; 21(6):367-8. PubMed ID: 3244769
    [No Abstract]   [Full Text] [Related]  

  • 51. Maprotiline in affective illness. Plasma concentration and clinical response.
    Norman TR; Burrows GD; Maguire KP; McIntyre IM; Scoggins BA
    J Affect Disord; 1983 May; 5(2):147-54. PubMed ID: 6222094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Results of the clinical trial with nomifensine (author's transl)].
    Kabes J; Balon R; Papezová H
    Cesk Psychiatr; 1981 Feb; 77(1):42-9. PubMed ID: 7018711
    [No Abstract]   [Full Text] [Related]  

  • 53. Severe depression treatment: experience using maprotiline (Ludiomil) in combination with clomipramine (Anafranil).
    Ovuga E
    East Afr Med J; 1985 Feb; 62(2):79-81. PubMed ID: 4042927
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical pharmacology of viloxazine hydrochloride.
    Vandel B; Vandel S; Allers G; Volmat R
    Pharmacopsychiatria; 1981 Mar; 14(2):66-70. PubMed ID: 7232498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Psychopharmacologic treatment of primary depression. Clinical experiments with nomifensine and imipramine].
    Ravizza L; Rebaudengo P; Boccalatte F
    Minerva Psichiatr; 1982; 23(2):87-92. PubMed ID: 7162382
    [No Abstract]   [Full Text] [Related]  

  • 56. Double-blind comparison of diclofensine with nomifensine in outpatients with dysphoric mood.
    Funke HJ; Holtmann W; Ismail S; Jansen W; Leonhardt KF; Muth H; Omer LM; O'Connolly M; Ramm H
    Pharmacopsychiatry; 1986 May; 19(3):120-3. PubMed ID: 3725890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Viloxazine in the treatment of depression in the aged. Double-blind placebo study].
    De Leo D; Ceola A; Magni G; Renesto V; Pacchioni A
    Minerva Psichiatr; 1984; 25(2):127-30. PubMed ID: 6387360
    [No Abstract]   [Full Text] [Related]  

  • 58. Nomifensine, imipramine and placebo in depressed outpatients.
    Rickels K; Weise CC; Sandler K; Schless A; Zal M; Norstad N
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():73-88. PubMed ID: 6752080
    [No Abstract]   [Full Text] [Related]  

  • 59. Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo.
    McEvoy JP; Sheridan WF; Stewart WR; Ban TA; Wilson WH; Guy W; Schaffer JD
    Br J Psychiatry; 1980 Nov; 137():440-3. PubMed ID: 7008890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of depression with maprotiline hydrochloride: multicenter evaluation of efficacy and tolerability.
    Clin Ther; 1983; 5(4):377-84. PubMed ID: 6347381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.